Engineered oncolytic virus for the treatment of cholesteatoma: A pilot in vivo study.
OBJECTIVE: Determine if oncolytic herpes simplex virus (oHSV) can eradicate cholesteatoma (CHST) in a gerbil model.
METHODS: An in vivo model of CHST was developed in Mongolian gerbils by combining
LEVEL OF EVIDENCE: NA.
Published In/Presented At
Samy, R. N., Earl, B. R., Lipschitz, N., Schweinzger, I., Currier, M., & Cripe, T. (2019). Engineered oncolytic virus for the treatment of cholesteatoma: A pilot in vivo study. Laryngoscope investigative otolaryngology, 4(5), 532–542. https://doi.org/10.1002/lio2.307
Medicine and Health Sciences
Department of Surgery